{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:10:25Z","timestamp":1792887025216,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00428-019-02607-8","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T19:03:25Z","timestamp":1561575805000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The molecular pathogenesis of penile carcinoma\u2014current developments and understanding"],"prefix":"10.1007","volume":"475","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0789-5279","authenticated-orcid":false,"given":"Anthony","family":"Emmanuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Nettleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Watkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"issue":"2","key":"2607_CR1","first-page":"126","volume":"67","author":"D Barski","year":"2014","unstructured":"Barski D, Georgas E, Gerullis H, Ecke T (2014) Metastatic penile carcinoma - an update on the current diagnosis and treatment options. Cent European J Urol 67(2):126\u2013132","journal-title":"Cent European J Urol"},{"issue":"1","key":"2607_CR2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2014","unstructured":"Hakenberg OW, Comperat EM, Minhas S, Necchi A, Protzel C, Watkin N (2014) EAU guidelines on penile cancer: 2014 update. Eur Urol 67(1):142\u2013150","journal-title":"Eur Urol"},{"issue":"3","key":"2607_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1756287211412657","volume":"3","author":"M Shabbir","year":"2011","unstructured":"Shabbir M, Minhas S, Muneer A (2011) Diagnosis and management of premalignant penile lesions. Ther Adv Urol 3(3):151\u2013158","journal-title":"Ther Adv Urol"},{"issue":"2","key":"2607_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.semdp.2011.08.009","volume":"29","author":"EF Velazquez","year":"2012","unstructured":"Velazquez EF, Chaux A, Cubilla AL (2012) Histologic classification of penile intraepithelial neoplasia. Semin Diagn Pathol 29(2):96\u2013102","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"2607_CR5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","volume":"69","author":"L Alemany","year":"2016","unstructured":"Alemany L, Cubilla A, Halec G, Kasamatsu E, Quiros B, Masferrer E et al (2016) Role of human papillomavirus in penile carcinomas worldwide. Eur Urol 69(5):953\u2013961","journal-title":"Eur Urol"},{"issue":"1","key":"2607_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.juro.2012.08.082","volume":"189","author":"MJ Longpre","year":"2013","unstructured":"Longpre MJ, Lange PH, Kwon JS, Black PC (2013) Penile carcinoma: lessons learned from vulvar carcinoma. J Urol 189(1):17\u201324","journal-title":"J Urol"},{"issue":"2","key":"2607_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2613.2008.00636.x","volume":"90","author":"D Krustrup","year":"2009","unstructured":"Krustrup D, Jensen HL, van den Brule AJ, Frisch M (2009) Histological characteristics of human papilloma-virus-positive and -negative invasive and in situ squamous cell tumours of the penis. Int J Exp Pathol 90(2):182\u2013189","journal-title":"Int J Exp Pathol"},{"issue":"3","key":"2607_CR8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.currproblcancer.2015.03.010","volume":"39","author":"M Christodoulidou","year":"2015","unstructured":"Christodoulidou M, Sahdev V, Houssein S, Muneer A (2015) Epidemiology of penile cancer. Curr Probl Cancer 39(3):126\u2013136","journal-title":"Curr Probl Cancer"},{"issue":"5","key":"2607_CR9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","volume":"8","author":"O Kayes","year":"2007","unstructured":"Kayes O, Ahmed HU, Arya M, Minhas S (2007) Molecular and genetic pathways in penile cancer. Lancet Oncol 8(5):420\u2013429","journal-title":"Lancet Oncol"},{"issue":"5","key":"2607_CR10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mds635","volume":"24","author":"G Sonpavde","year":"2013","unstructured":"Sonpavde G, Pagliaro LC, Buonerba C, Dorff TB, Lee RJ, Di Lorenzo G (2013) Penile cancer: current therapy and future directions. Ann Oncol 24(5):1179\u20131189","journal-title":"Ann Oncol"},{"issue":"24","key":"2607_CR11","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851\u20133857","journal-title":"J Clin Oncol"},{"issue":"10","key":"2607_CR12","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","volume":"109","author":"S Nicholson","year":"2013","unstructured":"Nicholson S, Hall E, Harland SJ, Chester JD, Pickering L, Barber J, Elliott T, Thomson A, Burnett S, Cruickshank C, Carrington B, Waters R, Bahl A (2013) Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001). Br J Cancer 109(10):2554\u20132559","journal-title":"Br J Cancer"},{"issue":"3","key":"2607_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clgc.2015.08.001","volume":"14","author":"A Necchi","year":"2015","unstructured":"Necchi A, Giannatempo P, Lo Vullo S, Raggi D, Nicolai N, Colecchia M et al (2015) Panitumumab treatment for advanced penile squamous cell carcinoma when surgery and chemotherapy have failed. Clin Genitourin Cancer 14(3):231\u2013236","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"2607_CR14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000315432","volume":"85","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Li H, Yao X-D, Zhang S-L, Zhang H-L, Shi G-H et al (2014) Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report. Urol Int 85(3):334\u2013340","journal-title":"Urol Int"},{"issue":"4","key":"2607_CR15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/PAS.0000000000000779","volume":"41","author":"S Canete-Portillo","year":"2017","unstructured":"Canete-Portillo S, Clavero O, Sanchez DF, Silvero A, Abed F, Rodriquez IM et al (2017) Medullary carcinoma of the penis: a distinctive HPV-related neoplasm: a report of 12 cases. Am J Surg Pathol 41(4):535\u2013540","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2607_CR16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/his.13429","volume":"72","author":"AL Cubilla","year":"2018","unstructured":"Cubilla AL, Velazquez EF, Amin MB, Epstein J, Berney DM, Corbishley CM, Members of the ISUP Penile Tumor Panel (2018) The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology Expert-Driven Recommendations. Histopathology. 72(6):893\u2013904","journal-title":"Histopathology."},{"issue":"3","key":"2607_CR17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.semdp.2014.12.018","volume":"32","author":"DF Sanchez","year":"2015","unstructured":"Sanchez DF, Canete S, Fernandez-Nestora MJ, Lezcano C, Rodriquez I, Barreto J, Alvarado-Cabrero I et al (2015) HPV-and non-HPB related subtypes of penile squamous cell carcinoma (SCC): morphological features and differential diagnosis according to the new WHO classification (2015). Semin Diagn Pathol 32(3):198\u2013221","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"2607_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.humpath.2012.01.014","volume":"43","author":"A Chaux","year":"2012","unstructured":"Chaux A, Cubilla AL (2012) Advances in the pathology of penile carcinomas. Hum Pathol 43(6):771\u2013789","journal-title":"Hum Pathol"},{"issue":"2 Suppl 1","key":"2607_CR19","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.urology.2010.02.038","volume":"76","author":"A Chaux","year":"2010","unstructured":"Chaux A, Velazquez EF, Algaba F, Ayala G, Cubilla AL (2010) Developments in the pathology of penile squamous cell carcinomas. Urology. 76(2 Suppl 1):S7\u2013s14","journal-title":"Urology."},{"issue":"3","key":"2607_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2559.2011.03762.x","volume":"58","author":"E Stankiewicz","year":"2011","unstructured":"Stankiewicz E, Prowse DM, Ktori E, Cuzick J, Ambroisine L, Zhang X, Kudahetti S, Watkin N, Corbishley C, Berney DM (2011) The retinoblastoma protein\/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma. Histopathology. 58(3):433\u2013439","journal-title":"Histopathology."},{"issue":"2","key":"2607_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","volume":"27","author":"MC Bleeker","year":"2009","unstructured":"Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ (2009) Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 27(2):141\u2013150","journal-title":"World J Urol"},{"issue":"2","key":"2607_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0b013e318203cdba","volume":"35","author":"AL Cubilla","year":"2011","unstructured":"Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, Monfulleda N, Tous S, Alemany L, Klaustermeier J, Mu\u00f1oz N, Quint W, de Sanjose S, Bosch FX (2011) Value of p16(INK)(4)(a) in the pathology of invasive penile squamous cell carcinomas: a report of 202 cases. Am J Surg Pathol 35(2):253\u2013261","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2607_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2012.05.029","volume":"68","author":"C Ferrandiz-Pulido","year":"2013","unstructured":"Ferrandiz-Pulido C, Masferrer E, de Torres I, Lloveras B, Hernandez-Losa J, Mojal S et al (2013) Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis. J Am Acad Dermatol 68(1):73\u201382","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2607_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PAS.0b013e3181cdad23","volume":"34","author":"A Chaux","year":"2010","unstructured":"Chaux A, Pfanni R, Lloveras B, Alejo M, Clavero O, Lezcano C et al (2010) Distinctive association of p16ink4a overpression with penile intraepithelial neoplasia depicting warty and\/or basaloid features: a study of 141 cases evaluating a new nomenclature. Am J Surg Pathol 34(3):385\u2013392","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2607_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2340\/00015555-3083","volume":"99","author":"S Kristiansen","year":"2018","unstructured":"Kristiansen S, Svensson A, Drevin L, Forslund O, Torbrand C, Biartling C (2018) Risk factors for penile intraepithelial neoplasia: a population-based registry study in Sweden, 2000-2012. Acta Derm Venereol 99(3):315\u2013320","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"2607_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.605","volume":"19","author":"T Yugawa","year":"2009","unstructured":"Yugawa T, Kiyono T (2009) Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 19(2):97\u2013113","journal-title":"Rev Med Virol"},{"issue":"9","key":"2607_CR27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0b013e31828b6be4","volume":"37","author":"N Guimera","year":"2013","unstructured":"Guimera N, Lloveras B, Lindeman J, Alemany L, van de Sandt M, Alejo M et al (2013) The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection\/PCR methodology: results from a global study. Am J Surg Pathol 37(9):1299\u20131310","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2607_CR28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/bbrc.2001.4838","volume":"283","author":"CS Yoon","year":"2001","unstructured":"Yoon CS, Kim KD, Park SN, Cheong SW (2001) alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun 283(3):668\u2013673","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"2607_CR29","first-page":"4620","volume":"56","author":"SN Boyer","year":"1996","unstructured":"Boyer SN, Wazer DE, Band V (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56(20):4620\u20134624","journal-title":"Cancer Res"},{"issue":"1","key":"2607_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/path.1394","volume":"201","author":"E Ferreux","year":"2003","unstructured":"Ferreux E, Lont AP, Horenblas S, Gallee MP, Raaphorst FM, von Knebel Doeberitz M et al (2003) Evidence for at least three alternative mechanisms targeting the p16INK4A\/cyclin D\/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 201(1):109\u2013118","journal-title":"J Pathol"},{"key":"2607_CR31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12885-015-1268-z","volume":"15","author":"J Steinestel","year":"2015","unstructured":"Steinestel J, Al Ghazal A, Arndt A, Schnoeller TJ, Schrader AJ, Moeller P et al (2015) The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma. BMC Cancer 15:220","journal-title":"BMC Cancer"},{"issue":"6569","key":"2607_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/380079a0","volume":"380","author":"AJ Klingelhutz","year":"1996","unstructured":"Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 380(6569):79\u201382","journal-title":"Nature."},{"issue":"18","key":"2607_CR33","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1101\/gad.1214704","volume":"18","author":"L Gewin","year":"2004","unstructured":"Gewin L, Myers H, Kiyono T, Galloway DA (2004) Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6\/E6-AP complex. Genes Dev 18(18):2269\u20132282","journal-title":"Genes Dev"},{"issue":"1","key":"2607_CR34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.juro.2011.09.027","volume":"187","author":"AA De Paula","year":"2012","unstructured":"De Paula AA, Motta ED, Alencar Rde C, Saddi VA, da Silva RC, Caixeta GN et al (2012) The impact of cyclooxygenase-2 and vascular endothelial growth factor C immunoexpression on the prognosis of penile carcinoma. J Urol 187(1):134\u2013140","journal-title":"J Urol"},{"issue":"3","key":"2607_CR35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C et al (2009) The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 30(3):377\u2013386","journal-title":"Carcinogenesis."},{"issue":"2","key":"2607_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","volume":"458","author":"M Poetsch","year":"2011","unstructured":"Poetsch M, Hemmerich M, Kakies C, Kleist B, Wolf E, vom Dorp F, Hakenberg OW, Protzel C (2011) Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 458(2):221\u2013229","journal-title":"Virchows Arch"},{"issue":"10","key":"2607_CR37","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/jmv.24833","volume":"89","author":"LA Afonso","year":"2017","unstructured":"Afonso LA, Carestiato FN, Ornellas AA, Ornellas P, Rocha WM, Cordeiro TI, Lisboa DC, Alves GB, Cavalcanti SMB (2017) Human papillomavirus, Epstein-Barr virus and methylation status of p16ink4a in penile cancer. J Med Virol 89(10):1837\u20131843","journal-title":"J Med Virol"},{"issue":"1","key":"2607_CR38","first-page":"101","volume":"33","author":"A Ouban","year":"2003","unstructured":"Ouban A, Dellis J, Salup R, Morgan M (2003) Immunohistochemical expression of Mdm2 and p53 in penile verrucous carcinoma. Ann Clin Lab Sci 33(1):101\u2013106","journal-title":"Ann Clin Lab Sci"},{"issue":"4","key":"2607_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00428-008-0597-6","volume":"452","author":"N Yanagawa","year":"2008","unstructured":"Yanagawa N, Osakabe M, Hayashi M, Tamura G, Motoyama T (2008) Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas. Virchows Arch 452(4):377\u2013382","journal-title":"Virchows Arch"},{"issue":"6","key":"2607_CR40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00428-017-2110-6","volume":"470","author":"SF Faraj","year":"2017","unstructured":"Faraj SF, Gonzalez-Roibon N, Munari E, Sharma R, Burnett AL, CUbilla AL et al (2017) Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Virchows Arch 470(6):695\u2013701","journal-title":"Virchows Arch"},{"issue":"3","key":"2607_CR41","doi-asserted-by":"crossref","first-page":"e17517","DOI":"10.1371\/journal.pone.0017517","volume":"6","author":"E Stankiewicz","year":"2011","unstructured":"Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, Lu YJ, Watkin N, Corbishley C, Lam W, Berney DM (2011) Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One 6(3):e17517","journal-title":"PLoS One"},{"issue":"6","key":"2607_CR42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","volume":"113","author":"BC Carthon","year":"2014","unstructured":"Carthon BC, Ng CS, Pettaway CA, Pagliaro LC (2014) Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis. BJU Int 113(6):871\u2013877","journal-title":"BJU Int"},{"key":"2607_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.humpath.2016.07.041","volume":"61","author":"AM Silva Amancio","year":"2017","unstructured":"Silva Amancio AM, Cunha IW, Neves JI, Quetz JD, Carraro DM, Rocha RM et al (2017) Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis. Hum Pathol 61:97\u2013104","journal-title":"Hum Pathol"},{"issue":"22","key":"2607_CR44","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.18632\/oncotarget.24688","volume":"9","author":"A Adimonye","year":"2018","unstructured":"Adimonye A, Stankiewicz E, Kudahetti S, Trevisan G, Tinwell B, Corbishley C, Lu YJ, Watkin N, Berney D (2018) Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway. Oncotarget 9(22):16074\u201316086","journal-title":"Oncotarget"},{"issue":"10","key":"2607_CR45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/gcc.22274","volume":"54","author":"C Ferrandiz-Pulido","year":"2015","unstructured":"Ferrandiz-Pulido C, Hernandez-Losa J, Masferrer E, Vivancos A, Somoza R, Mares R et al (2015) Identification of somatic gene mutations in penile squamous cell carcinoma. Genes Chromosom Cancer 54(10):629\u2013637","journal-title":"Genes Chromosom Cancer"},{"issue":"5","key":"2607_CR46","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.juro.2007.12.040","volume":"179","author":"P Andersson","year":"2008","unstructured":"Andersson P, Kolaric A, Windahl T, Kirrander P, Soderkvist P, Karlsson MG (2008) PIK3CA, HRAS and KRAS gene mutations in human penile cancer. J Urol 179(5):2030\u20132034","journal-title":"J Urol"},{"issue":"4","key":"2607_CR47","doi-asserted-by":"crossref","first-page":"e62175","DOI":"10.1371\/journal.pone.0062175","volume":"8","author":"HF Gou","year":"2013","unstructured":"Gou HF, Li X, Qiu M, Cheng K, Li LH, Dong H, Chen Y, Tang Y, Gao F, Zhao F, Men HT, Ge J, Su JM, Xu F, Bi F, Gao JJ, Liu JY (2013) Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma. PLoS One 8(4):e62175","journal-title":"PLoS One"},{"issue":"6","key":"2607_CR48","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.juro.2013.06.015","volume":"190","author":"C Ferrandiz-Pulido","year":"2013","unstructured":"Ferrandiz-Pulido C, Masferrer E, Toll A, Hernandez-Losa J, Mojal S, Pujol RM, Ramon y Cajal S, de Torres I, Garcia-Patos V (2013) mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior. J Urol 190(6):2288\u20132295","journal-title":"J Urol"},{"issue":"6","key":"2607_CR49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/his.12338","volume":"64","author":"A Chaux","year":"2014","unstructured":"Chaux A, Munari E, Cubilla AL, Hicks J, Lecksell K, Burnett AL, Netto GJ (2014) Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Histopathology. 64(6):863\u2013871","journal-title":"Histopathology."},{"issue":"16","key":"2607_CR50","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","volume":"76","author":"A Feber","year":"2016","unstructured":"Feber A, Worth DC, Chakravarthy A, de Winter P, Shah K, Arya M, Saqib M, Nigam R, Malone PR, Tan WS, Rodney S, Freeman A, Jameson C, Wilson GA, Powles T, Beck S, Fenton T, Sharp TV, Muneer A, Kelly JD (2016) CSN1 somatic mutations in penile squamous cell carcinoma. Cancer Res 76(16):4720\u20134727","journal-title":"Cancer Res"},{"issue":"2","key":"2607_CR51","doi-asserted-by":"crossref","first-page":"e0146740","DOI":"10.1371\/journal.pone.0146740","volume":"11","author":"S La-Touche","year":"2016","unstructured":"La-Touche S, Lemetre C, Lambros M, Stankiewicz E, Ng CK, Weigelt B et al (2016) DNA copy number aberrations, and human papillomavirus status in penile carcinoma. Clinico-pathological correlations and potential driver genes. PLoS One 11(2):e0146740","journal-title":"PLoS One"},{"key":"2607_CR52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-14-0284","volume":"8","author":"AF Busso-Lopes","year":"2015","unstructured":"Busso-Lopes AF, Marchi FA, Kuasne H, Scapulatempo-Neto C, Trindade-Filho JC, de Jesus CM et al (2015) Genomic profiling of human penile carcinoma predicts worse prognosis and survival. Cancer Prev Res (Phila) 8. United States: 2014 American Association for Cancer Research.:149\u2013156","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"2607_CR53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.juro.2016.01.115","volume":"196","author":"JM Hartz","year":"2016","unstructured":"Hartz JM, Engelmann D, Furst K, Marquardt S, Spitschak A, Goody D et al (2016) Integrated loss of miR-1\/miR-101\/miR-204 discriminates metastatic from nonmetastatic penile carcinomas and can predict patient outcome. J Urol 196(2):570\u2013578","journal-title":"J Urol"},{"issue":"1","key":"2607_CR54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.juro.2014.11.097","volume":"194","author":"JJ Munoz","year":"2015","unstructured":"Munoz JJ, Drigo SA, Barros-Filho MC, March FA, Scapulatempo-Neto C, Pessoa GS et al (2015) Down-regulation of SLC8A1 as a putative apoptosis mechanism by modulation of calcium levels in penile carcinoma. J Urol 194(1):245\u2013251","journal-title":"J Urol"},{"issue":"7","key":"2607_CR55","doi-asserted-by":"crossref","first-page":"e0131336","DOI":"10.1371\/journal.pone.0131336","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wei P, Shen X, Zhang Y, Xu B, Zhou J, Fan S, Hao Z, Shi H, Zhang X, Kong R, Xu L, Gao J, Zou D, Liang C (2015) MicroRNA expression profile in penile cancer revealed by next generation small RNA sequencing. PLoS One 10(7):e0131336","journal-title":"PLoS One"},{"issue":"9","key":"2607_CR56","doi-asserted-by":"crossref","first-page":"15294","DOI":"10.18632\/oncotarget.14783","volume":"8","author":"H Kuasne","year":"2017","unstructured":"Kuasne H, Barros-Filho MC, Busso-Lopes A, Marchi FA, Pinheiro M, Munoz JJ et al (2017) Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact. Oncotarget 8(9):15294\u201315306","journal-title":"Oncotarget"},{"issue":"9","key":"2607_CR57","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","volume":"27","author":"AM Udager","year":"2016","unstructured":"Udager AM, Liu TY, Skala SL, Mager MJ, McDaniel AS, Spratt DE et al (2016) Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol 27(9):1706\u20131712","journal-title":"Ann Oncol"},{"issue":"3 Pt 1","key":"2607_CR58","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","volume":"197","author":"SR Ottenhof","year":"2017","unstructured":"Ottenhof SR, Djajadiningrat RS, de Jong J, Thygesen HH, Horenblas S, Jordanova ES (2017) Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status. J Urol 197(3 Pt 1):690\u2013697","journal-title":"J Urol"},{"issue":"24","key":"2607_CR59","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel AS, Hovelson DH, Cani AK, Liu CJ, Zhai Y, Zhang Y et al (2015) Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy. Cancer Res 75(24):5219\u20135227","journal-title":"Cancer Res"},{"issue":"4","key":"2607_CR60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11033-018-4197-5","volume":"45","author":"LF Araujo","year":"2018","unstructured":"Araujo LF, Terra AT Jr, Sares CTG, Sobreira CFR, Faria EF, Machado RD (2018) Mitochondrial genome analysis in penile carcinoma. Mol Biol Rep 45(4):591\u2013600","journal-title":"Mol Biol Rep"},{"issue":"13","key":"2607_CR61","doi-asserted-by":"crossref","first-page":"21710","DOI":"10.18632\/oncotarget.15558","volume":"8","author":"ES Yang","year":"2017","unstructured":"Yang ES, Willey CD, Mehta A, Crowley MR, Crossman DK, Chen D, Anderson JC, Naik G, Della Manna DL, Cooper TS, Sonpavde G (2017) Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets. Oncotarget 8(13):21710\u201321718","journal-title":"Oncotarget"},{"issue":"1","key":"2607_CR62","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1038\/s41598-017-06659-1","volume":"7","author":"FA Marchi","year":"2017","unstructured":"Marchi FA, Martins DC, Barros-Filho MC, Kuasne H, Busso Lopes AF, Brentani H, Trindade Filho JCS, Guimar\u00e3es GC, Faria EF, Scapulatempo-Neto C, Lopes A, Rogatto SR (2017) Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma. Sci Rep 7(1):6707","journal-title":"Sci Rep"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02607-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T23:15:55Z","timestamp":1593040555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02607-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2607"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02607-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has full adherence and compliance to ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}